Nutrition Bar Improves Metabolic Biomarkers Linked to Cardiovascular Disease, Cognitive Decline and Anti-Oxidant Defenses

Scientists at the Children’s Hospital Oakland Research Institute (CHORI) Nutrition & Metabolism Center recently announced that they have developed a low-calorie, high-fiber, fruit-based vitamin and mineral nutrition bar called the CHORI-bar, which improves biomarkers linked to risk of cardiovascular disease, cognitive decline, and associated decline in antioxidant defenses.

Children’s Hospital Oakland Research Institute

Complete Genomics: Top Innovative Company in Biomedicine

Complete Genomics is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].

Complete Genomics

AssureRx Health Launches Personalized Medicine Test for ADHD

Mason, Ohio-based AssureRx Health announced this week that it has launched a personalized medicine test for attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test — GeneSightRx ADHD — analyzes variations in three genes that influence how a patient might metabolize certain medications used to treat ADHD in children and adults.

AssureRx Health

Mitochondria Dysfunction Occurs Early in Alzheimer’s Disease Prior to Memory Loss, Amyloid Deposits

Mitochondria are specialized subunits inside a cell that produce the cell’s energy and regulate its metabolism. Research suggests that mitochondria may play a central role in neuronal cell survival because they regulate both energy metabolism and cell death pathways. Using genetic mouse models of Alzheimer’s disease, researchers from Mayo Clinic have found that mitochondria in the brain are dysfunctional early in the disease. The findings were recently published in the open access journal PLoS ONE.

Mitochondria

Foundation Medicine: Top Innovative Company in Biomedicine

Foundation Medicine is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].

Foundation Medicine